CN102552486A - Preparation method of anti-hepatitis B virus oral liquid - Google Patents
Preparation method of anti-hepatitis B virus oral liquid Download PDFInfo
- Publication number
- CN102552486A CN102552486A CN2012100860282A CN201210086028A CN102552486A CN 102552486 A CN102552486 A CN 102552486A CN 2012100860282 A CN2012100860282 A CN 2012100860282A CN 201210086028 A CN201210086028 A CN 201210086028A CN 102552486 A CN102552486 A CN 102552486A
- Authority
- CN
- China
- Prior art keywords
- container
- hepatitis
- liquid
- decoction
- warming
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 65
- 208000002672 hepatitis B Diseases 0.000 title claims abstract description 28
- 241000701076 Macacine alphaherpesvirus 1 Species 0.000 title claims abstract description 22
- 238000002360 preparation method Methods 0.000 title abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 41
- 238000010792 warming Methods 0.000 claims description 30
- 238000000034 method Methods 0.000 claims description 15
- 238000007654 immersion Methods 0.000 claims description 6
- 239000009636 Huang Qi Substances 0.000 claims description 5
- 239000012467 final product Substances 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- 229910001220 stainless steel Inorganic materials 0.000 claims description 2
- 239000010935 stainless steel Substances 0.000 claims description 2
- 241000700721 Hepatitis B virus Species 0.000 abstract description 4
- 230000036039 immunity Effects 0.000 abstract description 2
- 241000594402 Damnacanthus Species 0.000 abstract 2
- 238000010438 heat treatment Methods 0.000 abstract 2
- 238000003756 stirring Methods 0.000 abstract 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000130781 Arnebia Species 0.000 abstract 1
- 240000001659 Oldenlandia diffusa Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 241001106477 Paeoniaceae Species 0.000 abstract 1
- 241000915604 Scutellaria barbata Species 0.000 abstract 1
- 238000009835 boiling Methods 0.000 abstract 1
- 238000005034 decoration Methods 0.000 abstract 1
- 235000012907 honey Nutrition 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 14
- 239000000427 antigen Substances 0.000 description 8
- 102000036639 antigens Human genes 0.000 description 8
- 108091007433 antigens Proteins 0.000 description 8
- 239000008280 blood Substances 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000006260 foam Substances 0.000 description 3
- 238000009533 lab test Methods 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 206010059193 Acute hepatitis B Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 101710142246 External core antigen Proteins 0.000 description 1
- 206010019668 Hepatic fibrosis Diseases 0.000 description 1
- 206010019695 Hepatic neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010041660 Splenomegaly Diseases 0.000 description 1
- 208000037628 acute hepatitis B virus infection Diseases 0.000 description 1
- 230000001064 anti-interferon Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 238000004383 yellowing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a preparation method of an anti-hepatitis B virus oral liquid. The preparation method comprises the following steps of: separately decocting Indian damnacanthus herb, pouring two thirds of a liquid in a decoration container out, adding clear water into the decoction container of the remaining liquid till the volume is 400-600ml, putting 10-20g of sinkiang arnebia root into the decoctin container, heating together with the Indian damnacanthus herb to 100 DEG C, pouring one third of a liquid in the decoction container out, putting 35-45g of barbed skullcap herb, 15-25g of Chinese angelica, 15-25g of red paeony root, 40-60g of spreading hedyotis herb and 60-100g of chickenbone herb into the decoction container, heating to 100 DEG C, and preserving heat for 30 minutes; and adding honey in an amount of 17-25 percent based on the total weight of a decoction obtained in steps 1 to 5 into the decoction container, boiling, stirring till a liquid becomes yellow, pouring all of the decoctions obtained in the steps 1 to 5 into the decoction container, and stirring and mixing uniformly. According to the anti-hepatitis B virus oral liquid, the mechanism resistivity of a human body can be enhanced, the immunity is improved, duplication of hepatitis B viruses can be suppressed, and hepatitis B viruses are wounded and killed.
Description
Technical field
The present invention relates to a kind of method for preparing of medicine, be specifically related to a kind of method for preparing of anti-hepatitis B virus oral liquid.
Background technology
Use the Western medicine anti-hepatitis B virus, the medicine high price is expensive, and side effect is big; Take for a long time be prone to the variation and drug resistance, can cause again after the drug withdrawal knock-on or sb.'s illness took a turn for the worse, though HBV-DNA turns out cloudy comparatively fast; But the frequence of seroconversion of the 1 year HBeAg that takes medicine is very low, so antiviral is difficult to reach therapeutic effect at present.Even if reached therapeutic effect, the state of an illness still possibly rebound after the drug withdrawal, and hepatic fibrosis, splenomegaly continue development, still occur liver cirrhosis easily.And the existing Chinese medicine anti-hepatitis B virus of using, its key is exactly a Chinese medicine preparation compatibility inaccuracy, complex manufacturing technology, and loss of effective components is more in the medicine causes that drug effect is slow, the course of treatment is long, has also strengthened patient's treatment cost.
Summary of the invention
It is accurate to the purpose of this invention is to provide a kind of compatibility, and processing technology is simple, the method for preparing of the anti-hepatitis B virus oral liquid that loss of effective components is few in the medicine.
The method for preparing of a kind of anti-hepatitis B virus oral liquid of the present invention realizes according to the following steps: one, Herba Damnacanthi 45～55 grams are put into the decoction container that 400～600ml clear water is housed; There is the water of Herba Damnacanthi to be warming up to 70～90 ℃ immersion, will decocts liquid in the container then and pour out 2/3rds to 4/5ths subsequent use in sterile chamber; Two, in the decoction container of remaining liquid, add clear water to 400～600ml again; Radix Arnebiae (Radix Lithospermi) 10～20 gram put into decoct container and be warming up to together with Herba Damnacanthi that to pour out 1/3rd to 1/2nd liquid after 100 ℃ subsequent use in sterile chamber; In the decoction container of remaining liquid, add clear water to 450～600ml; Again Herba Scutellariae Barbatae 35～45 gram, Radix Angelicae Sinensis 15～25 grams, Radix Paeoniae Rubra 15～25 grams, Herba Hedyotidis Diffusae 40～60 grams and Herba Abri 60～100 grams are put into and decocted container and be warming up to 100 ℃ and be incubated 30 minutes; The liquid that will decoct then in the container is all poured in the sterile chamber, place at ambient temperature 10～14 hours subsequent use; Three, in decocting container, add clear water, clear water is higher than solids 55～70mm, is warming up to 100 ℃, all pours in the sterile chamber liquid subsequent use; Four, the Radix Polygoni Multiflori 25～35 grams are put into the decoction container; In decocting container, add clear water 450～600ml; Soak and in decocting container, add clear water 900～1200ml after 25～40 minutes again; Boil to the complete deliquescing of the Radix Polygoni Multiflori, all pour in the sterile chamber subsequent usely, pour out dregs of a decoction decocting liquid in the container; Five, in decocting container, add clear water 700～900ml, put into the Radix Astragali 35～50 grams again, be warming up to 100 ℃, liquid is all poured in the sterile chamber subsequent use, medicinal residues are outwelled; Six, in decocting container, add the Mel that step 1 to five obtains decoction liquor gross weight 17～25%, boil (emitting foam),, be stirred to the liquid flavescence, step 1 to five is obtained decoction liquor all pour into to decoct to mix in the container and get final product from fire.
Oral liquid of the present invention is primarily aimed at acute hepatitis b patient and hepatitis B great three positive and small three positive patient, as long as carry out the five indexes of hepatitis b inspection at hospital outpatient, can take medicine of the present invention after making a definite diagnosis.Be the male patient of 100 hepatitis B surface antigens (HBsAg) have been carried out following the tracks of treatment statistical result, the usage and dosage of oral liquid below: every day twice, each 100ml; Sooner or later taking medicine before meal is used; Three months is a total course of treatment, and 30 days is a course of treatment, and the surface antigen of a course of treatment (HBsAg) negative conversion rate is 24%; Two surface antigens course of treatment (HBsAg) negative conversion rate is that 41%, three surface antigen course of treatment (HBsAg) negative conversion rate is 62%.Oral oral liquid of the present invention does not have contraindication.
Be three cases that hepatitis B great three positive patient takes oral liquid of the present invention below:
Medical record one, patient Lv, woman, 38 years old; Occupation: car lease car driver, medical history: finding during health check-up in 24 years old to suffer from hepatitis B, is great three positive; Once hospitalization was not repeatedly cured yet; Result of laboratory test showed 64 times of surface antigens, began to take anti-hepatitis B virus oral liquid of the present invention in 2007, cured after three courses of treatment.
Medical record two, patient king so-and-so, the man, 50 years old, the cadre once lived the front three hospitalize repeatedly, used anti-interferon treatment three months, take a turn for the better, but result of laboratory test remained the hepatitis B great three positive, 32 times of surface antigens.The back begins to take anti-hepatitis B virus oral liquid of the present invention in August, 2009, and surface antigen was turned out cloudy after result of laboratory test display surface antigen dropped to 6.7, three courses of treatment from original 18.9 after taking medicine 17 days, followed the tracks of to follow up a case by regular visits to and did not see recurrence.
Medical record three, patient Yang, man, 53 years old, cadre; Find the hepatitis B great three positive through health check-up, the back merges liver tumor, and in December, 2009 is hospital surgical in Shanghai, does not take out stitches in one week of postoperative and just goes home by train; Nearly 30 hours journey, patient's tripe abdominal distention gas are painful especially, once the emergency aid and treatment of coming of detraining, and 100 milliliters of oral at once anti-hepatitis B virus oral liquids; Obey and promptly began aerofluxus in back 30 minutes, abdominal distention is alleviated, for consolidating effect; The back is every obeyed once at a distance from two hours, each 100 milliliters, obey six bottles after flatulence thoroughly disappear.Big and small three Yang was all turned out cloudy in three months, followed up a case by regular visits to and did not have recurrence in 3 years.
In the compatibility of the present invention, Herba Damnacanthi is used for expelling wind and removing dampness, promoting blood circulation and detumescence, and Radix Arnebiae (Radix Lithospermi) is used for removing heat from blood and promoting blood circulation; Herba Scutellariae Barbatae is used for heat clearing away, blood detoxifies, dispels the wind, looses; Radix Angelicae Sinensis is used to enrich blood, invigorate blood circulation; Radix Paeoniae Rubra is used for clearing away heat and cooling blood, promoting blood circulation to remove blood stasis; Herba Hedyotidis Diffusae has the function of heat-clearing and toxic substances removing, inducing diuresis to remove edema, promoting blood circulation and stopping pain; Radix Polygoni Multiflori liver and kidney tonifying, benefiting essence-blood, strengthening bone and muscle; Radix Astragali invigorating QI to consolidate the body surface resistance, diuresis poison holding, evacuation of pus, expelling pus and promoting granulation; Mel can harmonizing the spleen and stomach, relieving spasm to stop pain, nourishing the lung to arrest cough, loosening bowel to relieve constipation, skin moistening granulation promoting, detoxifcation, and Mel also has protective effect to liver, can impel liver cell regeneration.Oral liquid compatibility of the present invention is accurate, and processing technology is simple, and loss of effective components is few in the medicine.Medicine of the present invention can improve the physiological function and the immunity of human body, can suppress duplicating of hepatitis B virus, finally removes hepatitis B virus.The present invention adopts natural Chinese medicine, and toxic and side effects is not found in clinical use.
The specific embodiment
The specific embodiment one: the method for preparing of a kind of anti-hepatitis B virus oral liquid of this embodiment realizes according to the following steps: one, Herba Damnacanthi 45～55 grams are put into the decoction container that 400～600ml clear water is housed; There is the water of Herba Damnacanthi to be warming up to 70～90 ℃ immersion, will decocts liquid in the container then and pour out 2/3rds to 4/5ths subsequent use in sterile chamber; Two, in the decoction container of remaining liquid, add clear water to 400～600ml again; Radix Arnebiae (Radix Lithospermi) 10～20 gram put into decoct container and be warming up to together with Herba Damnacanthi that to pour out 1/3rd to 1/2nd liquid after 100 ℃ subsequent use in sterile chamber; In the decoction container of remaining liquid, add clear water to 450～600ml; Again Herba Scutellariae Barbatae 35～45 gram, Radix Angelicae Sinensis 15～25 grams, Radix Paeoniae Rubra 15～25 grams, Herba Hedyotidis Diffusae 40～60 grams and Herba Abri 60～100 grams are put into and decocted container and be warming up to 100 ℃ and be incubated 30 minutes; The liquid that will decoct then in the container is all poured in the sterile chamber, place at ambient temperature 10～14 hours subsequent use; Three, in decocting container, add clear water, clear water is higher than solids 55～70mm, is warming up to 100 ℃, all pours in the sterile chamber liquid subsequent use; Four, the Radix Polygoni Multiflori 25～35 grams are put into the decoction container; In decocting container, add clear water 450～600ml; Soak and in decocting container, add clear water 900～1200ml after 25～40 minutes again; Boil to the complete deliquescing of the Radix Polygoni Multiflori, all pour in the sterile chamber subsequent usely, pour out dregs of a decoction decocting liquid in the container; Five, in decocting container, add clear water 700～900ml, put into the Radix Astragali 35～50 grams again, be warming up to 100 ℃, liquid is all poured in the sterile chamber subsequent use, medicinal residues are outwelled; Six, in decocting container, add the Mel that step 1 to five obtains decoction liquor gross weight 17～25%, boil (emitting foam),, be stirred to the liquid flavescence, step 1 to five is obtained decoction liquor all pour into to decoct to mix in the container and get final product from fire.
The specific embodiment two: the method for preparing of a kind of anti-hepatitis B virus oral liquid of this embodiment is a preferred embodiment; The steps include: one, Herba Damnacanthi 50 grams are put into the decoction container that the 500ml clear water is housed; There is the water of Herba Damnacanthi to be warming up to 80 ℃ immersion, will decocts liquid in the container then and pour out 2/3rds subsequent use in sterile chamber; Two, in the decoction container of remaining 1/3rd liquid, add clear water again to 500ml; Radix Arnebiae (Radix Lithospermi) 15 gram put into decoct container and be warming up to together with Herba Damnacanthi that to pour out 1/3rd liquid after 100 ℃ subsequent use in sterile chamber; In the decoction container of remaining 2/3rds liquid, add clear water to 500ml; Again Herba Scutellariae Barbatae 40 gram, Radix Angelicae Sinensis 20 grams, Radix Paeoniae Rubra 20 grams, Herba Hedyotidis Diffusae 50 grams and Herba Abri 80 grams are put into and decocted container and be warming up to 100 ℃ and be incubated 30 minutes; The liquid that will decoct then in the container is all poured in the sterile chamber, place at ambient temperature 12 hours subsequent use; Three, in decocting container, add clear water, clear water is higher than solids 60mm, is warming up to 100 ℃, all pours in the sterile chamber liquid subsequent use; Four, the Radix Polygoni Multiflori 30 grams are put into the decoction container; In decocting container, add clear water 500ml, soaks after 30 minutes adding clear water 1000ml in decocting container again, boil to the complete deliquescing of the Radix Polygoni Multiflori; All pour in the sterile chamber subsequent usely with decocting liquid in the container, pour out dregs of a decoction; Five, in decocting container, add clear water 800ml, put into the Radix Astragali 40 grams again, be warming up to 100 ℃, liquid is all poured in the sterile chamber subsequent use, medicinal residues are outwelled; Six, in decocting container, add the Mel that step 1 to five obtains decoction liquor gross weight 20%, boil (emitting foam),, be stirred to the liquid yellowing, step 1 to five is obtained decoction liquor all pour into to decoct to mix in the container and get final product from fire.The airtight preservation of can under aseptic condition, bottling.Other are identical with the specific embodiment one.
The specific embodiment three: the described decoction container of this embodiment is stainless-steel pan or marmite.Other are identical with the specific embodiment one or two.
The specific embodiment four: the temperature of the said adding clear water of this embodiment is room temperature.Other are identical with the specific embodiment three.
The specific embodiment five: this embodiment is said, and immersion to be had the water of Herba Damnacanthi be warming up to 80 ℃ of used times by room temperature be 30 minutes.Other are identical with the specific embodiment three.
The specific embodiment six: said Radix Arnebiae (Radix Lithospermi) is put into of this embodiment decocts container to be warming up to 100 ℃ of used times together with Herba Damnacanthi by room temperature is 30 minutes.Other are identical with the specific embodiment three.
The specific embodiment seven: said Herba Scutellariae Barbatae, Radix Angelicae Sinensis, Radix Paeoniae Rubra, Herba Hedyotidis Diffusae and Herba Abri are put into of this embodiment decocts container to be warming up to 100 ℃ of used times by room temperature is 40 minutes.Other are identical with the specific embodiment three.
The specific embodiment eight: being warming up to 100 ℃ of used times by room temperature in the said step 3 of this embodiment is 30 minutes.Other are identical with the specific embodiment three.
The specific embodiment nine: being warming up to 100 ℃ of used times by room temperature in the said step 5 of this embodiment is 30 minutes.Other are identical with the specific embodiment three.
Claims (8)
1. the method for preparing of an anti-hepatitis B virus oral liquid; It is characterized in that; Realize according to the following steps: one, Herba Damnacanthi 45～55 grams are put into the decoction container that 400～600ml clear water is housed; There is the water of Herba Damnacanthi to be warming up to 70～90 ℃ immersion, will decocts liquid in the container then and pour out 2/3rds to 4/5ths subsequent use in sterile chamber; Two, in the decoction container of remaining liquid, add clear water to 400～600ml again; Radix Arnebiae (Radix Lithospermi) 10～20 gram put into decoct container and be warming up to together with Herba Damnacanthi that to pour out 1/3rd to 1/2nd liquid after 100 ℃ subsequent use in sterile chamber; In the decoction container of remaining liquid, add clear water to 450～600ml; Again Herba Scutellariae Barbatae 35～45 gram, Radix Angelicae Sinensis 15～25 grams, Radix Paeoniae Rubra 15～25 grams, Herba Hedyotidis Diffusae 40～60 grams and Herba Abri 60～100 grams are put into and decocted container and be warming up to 100 ℃ and be incubated 30 minutes; The liquid that will decoct then in the container is all poured in the sterile chamber, place at ambient temperature 10～14 hours subsequent use; Three, in decocting container, add clear water, clear water is higher than solids 55～70mm, is warming up to 100 ℃, all pours in the sterile chamber liquid subsequent use; Four, the Radix Polygoni Multiflori 25～35 grams are put into the decoction container; In decocting container, add clear water 450～600ml; Soak and in decocting container, add clear water 900～1200ml after 25～40 minutes again; Boil to the complete deliquescing of the Radix Polygoni Multiflori, all pour in the sterile chamber subsequent usely, pour out dregs of a decoction decocting liquid in the container; Five, in decocting container, add clear water 700～900ml, put into the Radix Astragali 35～50 grams again, be warming up to 100 ℃, liquid is all poured in the sterile chamber subsequent use, medicinal residues are outwelled; Six, in decocting container, add the Mel that step 1 to five obtains decoction liquor gross weight 17～25%, boil,, be stirred to the liquid flavescence, step 1 to five is obtained decoction liquor all pour into to decoct to mix in the container and get final product from fire.
2. the method for preparing of a kind of anti-hepatitis B virus oral liquid according to claim 1 is characterized in that, described decoction container is stainless-steel pan or marmite.
3. the method for preparing of a kind of anti-hepatitis B virus oral liquid according to claim 2 is characterized in that, the temperature of said adding clear water is room temperature.
4. the method for preparing of a kind of anti-hepatitis B virus oral liquid according to claim 3 is characterized in that, it is 30 minutes that the said water that immersion is had a Herba Damnacanthi is warming up to 80 ℃ of used times by room temperature.
5. the method for preparing of a kind of anti-hepatitis B virus oral liquid according to claim 3 is characterized in that, said Radix Arnebiae (Radix Lithospermi) is put into decocts container to be warming up to 100 ℃ of used times together with Herba Damnacanthi by room temperature be 30 minutes.
6. the method for preparing of a kind of anti-hepatitis B virus oral liquid according to claim 3; It is characterized in that said Herba Scutellariae Barbatae, Radix Angelicae Sinensis, Radix Paeoniae Rubra, Herba Hedyotidis Diffusae and Herba Abri are put into decocts container to be warming up to 100 ℃ of used times by room temperature be 40 minutes.
7. the method for preparing of a kind of anti-hepatitis B virus oral liquid according to claim 3 is characterized in that, being warming up to 100 ℃ of used times by room temperature in the said step 3 is 30 minutes.
8. the method for preparing of a kind of anti-hepatitis B virus oral liquid according to claim 3 is characterized in that, being warming up to 100 ℃ of used times by room temperature in the said step 5 is 30 minutes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210086028 CN102552486B (en) | 2012-03-28 | 2012-03-28 | Preparation method of anti-hepatitis B virus oral liquid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210086028 CN102552486B (en) | 2012-03-28 | 2012-03-28 | Preparation method of anti-hepatitis B virus oral liquid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102552486A true CN102552486A (en) | 2012-07-11 |
| CN102552486B CN102552486B (en) | 2013-07-24 |
Family
ID=46399941
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201210086028 Expired - Fee Related CN102552486B (en) | 2012-03-28 | 2012-03-28 | Preparation method of anti-hepatitis B virus oral liquid |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102552486B (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002032444A1 (en) * | 2000-10-18 | 2002-04-25 | Wu, Bertolotti, Jy-Yuan | Novel medicinal herbal composition for treating liver diseases and hiv |
| CN1385203A (en) * | 2002-05-31 | 2002-12-18 | 梅开丰 | Compound Chinese medicine preparation of damnacanthus |
| CN102048902A (en) * | 2010-12-22 | 2011-05-11 | 中国人民解放军第三○二医院 | Traditional Chinese medicine preparation and traditional Chinese medicine extract as well as preparation method, application and formulation of traditional Chinese medicine extract |
| CN102274438A (en) * | 2011-08-30 | 2011-12-14 | 莫桂森 | Oral powder for treating hepatitis B |
-
2012
- 2012-03-28 CN CN 201210086028 patent/CN102552486B/en not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002032444A1 (en) * | 2000-10-18 | 2002-04-25 | Wu, Bertolotti, Jy-Yuan | Novel medicinal herbal composition for treating liver diseases and hiv |
| CN1385203A (en) * | 2002-05-31 | 2002-12-18 | 梅开丰 | Compound Chinese medicine preparation of damnacanthus |
| CN102048902A (en) * | 2010-12-22 | 2011-05-11 | 中国人民解放军第三○二医院 | Traditional Chinese medicine preparation and traditional Chinese medicine extract as well as preparation method, application and formulation of traditional Chinese medicine extract |
| CN102274438A (en) * | 2011-08-30 | 2011-12-14 | 莫桂森 | Oral powder for treating hepatitis B |
Non-Patent Citations (2)
| Title |
|---|
| 侯中伟: "防治乙肝:千万别忘了绿色疗法", 《中华养生保健》 * |
| 崔华复: "茵蛇丹芪汤与联苯双酯联用治疗慢性乙型肝炎疗效观察", 《中国中西医结合消化杂志》 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102552486B (en) | 2013-07-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103040960A (en) | Traditional Chinese medicine formula for treating high blood pressure | |
| CN104043050A (en) | Traditional Chinese medicine composition for treating cholecystitis | |
| CN104383053B (en) | Traditional Chinese medicine preparation for treating urinary tract infection and production method of traditional Chinese medicine preparation | |
| CN101856421A (en) | Medicament for treating herpes zoster and preparation method thereof | |
| CN100998811A (en) | Orally taken Chinese medicine for treating accumulation of phlegm and heat in type bronchitis | |
| CN106421700A (en) | Traditional Chinese medicine liquor for promoting blood circulation to remove blood stasis and preparation and use method thereof | |
| CN101168032B (en) | Medicine for treating asthma | |
| CN102614451A (en) | Traditional Chinese medicine for warming channel to expelling cold, warming stomach to stop vomiting and removing dampness for improvement | |
| CN102100817A (en) | Chinese medicinal preparation for treating infection of upper respiratory tracts | |
| CN102552486B (en) | Preparation method of anti-hepatitis B virus oral liquid | |
| CN103463588A (en) | Traditional Chinese medicine composition for treating sinking of qi of middle-jiao | |
| CN105435195A (en) | Orally-taken medicine for treating prolonged lochia and lesser abdominal pain as well as preparation method of orally-taken medicine | |
| CN103735998A (en) | Traditional Chinese medicinal composition for treating haemorrhoids | |
| CN103432279B (en) | Method for preparing soaking agent for preventing and treating gout with decoction dregs and product | |
| CN103393883B (en) | Chinese medicinal composition for treating neonatal jaundice | |
| CN102784344B (en) | Traditional Chinese medicine preparation for treating pulmonary tuberculosis | |
| CN101002864B (en) | Decoction for treating old lumbar soft tissue injury, and its preparing method | |
| CN100998707B (en) | Medical herbs of decoction for treating sciatica and its preparing method | |
| CN105770655A (en) | Traditional Chinese medicine composition for treating scroti eczema | |
| CN105833151A (en) | Hippocampus and corn cervi pantotrichum tonic wine | |
| CN104824233A (en) | Loquat leaf liquorice health-preserving herbal tea beverage and preparation method | |
| CN103816364A (en) | Traditional Chinese medicine for treating upper respiratory infection | |
| CN104000941A (en) | Multi-traditional Chinese medicine mixed medicine for treating ankylosing spondylitis | |
| CN104147178A (en) | Internally-use traditional Chinese medicine pill for treating hysteromyoma and preparation method thereof | |
| CN104027751A (en) | Traditional Chinese medicine preparation for treating chronic cholecystitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130724 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |